CoChat

Fish Oil and the Management of Hypertriglyceridemia

Open access
Mattar, Melanie, Obeid, Omar · 2009 · Nutrition and Health

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Abstract

Hypertriglyceridemia, regarded as one of the independent clinical markers of metabolic syndrome, is a frequently observed disorder that has been shown to be common in the Arab region. Epidemiologic and clinical trials demonstrated that omega-3 fatty acids have the potential to reduce the incidence of cardiovascular disease (CVD); one of the mechanisms by which this effect is achieved is through reducing plasma triglyceride levels. There is strong scientific evidence from human trials that omega-3 fatty acids from either fish or fish oil supplements significantly reduce blood triglyceride levels and these benefits appear to be dose-dependent. The active ingredients of fish oils include the long chain fatty acids EPA and DHA. The ideal amount of omega-3 fatty acid that should be incorporated into the diet without provoking detrimental effects on other lipid components such as decreasing HDL-C and/or increasing LDL-C has not yet been elucidated. Presently, a prescription form of omega-3 fatty acid has been approved by the United States Food and Drug Administration (USFDA) as an adjunct to the diet for the treatment of very high triglyceride levels (~ 500 mg/dl) in adults. Patients with hypertriglyceridemia have been shown to respond well to the use of omega-3 fatty acids even when used in conjunction with statins where greater improvements in the lipid profile were found as compared to treatment with statins alone. A determinant of the responsiveness to fish oil could be attributed to the ApoE genotype of individuals.

Overview

Integrity signals

Registry

Crossref · 10.1177/026010600902000105

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 38 references

Research works printed but not linked: 4

  1. Al-Nozha M., 2005, Saudi Med J., 26, 1918
  2. Ebbesson S.O.E, 2007, JCMS., 2, 244
  3. GISSI-Prevenzione Trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico, 1999, Lancet, 7, 447
  4. Mori T.A., 2000, Best

Cited by

See all 49

Metadata

Authors
Mattar, M., & Obeid, O.
Affiliations
  • Department of Nutrition and Food Science, American University of Beirut
  • American University of Beirut (LB)
Venue
Nutrition and Health
Published
2009-01
Volume
20
Issue
1
Pages
41-49
ISSN
  • 0260-1060 (ISSN-L)
  • 2047-945X
OpenAlex
W1967898165
Cited by
43
References
38
Citations by year
2025: 1 · 2023: 4 · 2020: 2 · 2019: 1 · 2018: 4 · 2016: 2 · 2015: 1 · 2014: 3 · 2013: 4 · 2012: 2
FWCI
0.76
Type
journal article
Language
en
Open access
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Nutrition and Health (publishedVersion)
  • PubMed (publishedVersion)
  • Scopus
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Keywords
hypertriglyceridemia, fish oil, omega-3 fatty acids, EPA, docosahexaenoic acid, triglyceride lowering, metabolic syndrome, cardiovascular disease prevention, statin combination therapy, APOE genotype, lipid profile
MeSH terms
Hypolipidemic Agents, Consumer Product Safety, Dose-Response Relationship, Drug, Fish Oils, Humans, Triglycerides, Hypertriglyceridemia, Fatty Acids, Omega-3, Dietary Supplements, Food, Organic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Fish Oil and the Management of Hypertriglyceridemia. https://app.cochat.ai/papers/10.1177/026010600902000105
The paper
Mattar, M., & Obeid, O. (2009). Fish Oil and the Management of Hypertriglyceridemia. Nutrition and Health. https://doi.org/10.1177/026010600902000105

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.